Caribou Bioscience GAAP EPS of -$0.28 beats by $0.04, revenue of $3.94M beats by $1.98M
Source: SeekingAlpha
2026-03-05 16:37:35 ET
More on Caribou Bioscience
- Caribou Biosciences, Inc. (CRBU) Presents at 2026 Tandem Meetings of ASTCT and CIBMTR - Slideshow
- Caribou Biosciences a new buy at Clear Street on CAR-T pipeline
- Seeking Alpha’s Quant Rating on Caribou Bioscience
- Historical earnings data for Caribou Bioscience
- Financial information for Caribou Bioscience
Read the full article on Seeking Alpha
For further details see:
Caribou Bioscience GAAP EPS of -$0.28 beats by $0.04, revenue of $3.94M beats by $1.98M
Caribou Biosciences Inc.
NASDAQ: CRBU
CRBU Trading
-1.93% G/L:
$1.9123 Last:
375,240 Volume:
$1.93 Open:
CRBU Latest News
March 05, 2026 04:05:00 pm
Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
February 04, 2026 08:00:00 am
Caribou Biosciences Announces Late-Breaking Presentations at the 2026 Tandem Meetings of ASTCT® and CIBMTR®
December 24, 2025 06:00:00 am
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge
December 01, 2025 04:05:00 pm
Caribou Biosciences to Host In-Person and Virtual KOL Event at ASH 2025
CRBU Stock Data
$146,744,820
85,728,884
5.21%
42
N/A
Biotechnology & Life Sciences
Healthcare
US
Berkeley
